Aethlon Medical Inc (AEMD)

[garydaemon]

I researched her info and the source of the story is published in the Lancet today:
Severe Ebola virus disease with vascular leakage and multiorgan failure: treatment of a patient in intensive care

On day 13—after the haemodynamic situation had already stabilised—we used a haemofiltration cartridge (Haemopurifier; Aethlon, San Diego, CA, USA) for 6·5 h upstream to the regular system. This cartridge is designed to bind viral glycoproteins by lectin affinity. This one-time use was well tolerated. PCR measurements taken directly before and after the use showed virus loads of 2·29?×?105 copies per mL and 7·66?×?104 copies per mL, respectively. This difference of less than a factor of 3 is within the technical variability range of the RNA PCR assay for Ebola virus and cannot be judged as a notable decrease.